TBPH Stock-Based Compensation
Theravance Biopharma Inc · Stock-Based Compensation
TBPH Stock-Based Compensation
Latest reported$19.55Mperiod ending
TBPH Stock-Based Comp ($0.00 → $19.55M)
Annual stock-based compensation
High-resolution chart · PNG
TBPH stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 18,476,000 | |
| 21,393,000 | |
| 25,371,000 | |
| 39,734,000 | |
| 62,061,000 | |
| 62,976,000 | |
| 60,450,000 | |
| 51,313,000 | |
| 49,145,000 | |
| 41,169,000 | |
| 54,050,000 | |
| 43,234,000 | |
| 22,476,000 | |
| 21,323,000 | |
| 0 |